Metropolitan Life Insurance Company (MetLife)’s Blend Labs BLND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,983
Closed -$10.9K 2465
2023
Q1
$10.9K Sell
10,983
-889
-7% -$1.36K ﹤0.01% 2129
2022
Q4
$17.1K Hold
11,872
﹤0.01% 2093
2022
Q3
$26.2K Hold
11,872
﹤0.01% 1873
2022
Q2
$28K Buy
+11,872
New +$44.4K ﹤0.01% 1865

Other funds holding BLND

Metropolitan Life Insurance Company (MetLife)'s BLND Position: Q2 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Blend Labs (BLND) in Q2 2023, closing a stake of 10,983 shares — an estimated $10.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in BLND in Q2 2022 and held it in 4 quarters. The position peaked at $28K in Q2 2022. 93 funds tracked by Wall St. Rank hold BLND as of Q2 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Blend Labs position as of Q2 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 10,983 Blend Labs shares in Q2 2023, an estimated $10.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Blend Labs in Q2 2022 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Blend Labs position peaked at $28K in Q2 2022.
  • 93 funds tracked by Wall St. Rank held Blend Labs as of Q2 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.